Psychopharmacology of Child and Adolescent Major Depression: Present Status and Future Directions

Journal of Child and Adolescent Psychopharmacology

Volumn 2, Issue 1, 1992, Pages 31-45

  Jensen, Peter S ^a   Ryan, Neal D ^b   Prien, Robert ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012505693     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.1992.2.31     Document Type: Article

References (74)

1. Ambrosini P: Bianchi M, Metz C, Rabinovich H: Response patterns of open nortriptyline pharmacol therapy in adolescent major depression. J Child Adol Psychopharmacol, at press
2. Angold A: Childhood and adolescent depression: I. Epidemiologie and aetiologic aspects. Br J Psychiatry 152:601–617, 1988a
3. Angold A: Childhood and adolescent depression: II. Research in clinical populations. Br J Psychiatry 153:476–492, 1988b
4. Angold A, Weissman MM, John K, Merikangas KR, Prusoff BA, Wickramaratne P, Gammon GD, Warner V: Parent and child reports of depressive symptoms in children at low and high risk of depression. J Child Psychol Psychiat 28:901–915, 1987
5. Asberg M, Cronholm G, Sjoqvist F, Tuck D: Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3:331–334, 1971
6. Barrnett RJ, Docherty JP, Frommelt GM: A review of psychotherapy research since 1963. J Am Acad Child Adol Psychiatry 30:1–14, 1991
7. Beardslee W, Keller MB, Lavori PW, Klerman GK, Dorer DJ, Samuelson H: Psychiatric disorder in adolescent offspring of parents with affective disorder in a non-referred sample. J Affective Dis 15:313–322, 1988
8. Birmaher B: National Institute of Mental Health, Grant Number 1 R29 MH46894–01A1, 1991
9. Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N: Response to desipramine treatment in adolescent major depression. Psychopharm Bull 27:59–65, 1991
10. Briggs RS, Petersen MM, Cook PJ: Muscarinic agonist receptor subtypes in aging rat brain. Neurobiol Aging 3:157–189, 1982
11. Cloninger CR: Establishment of diagnostic validity in psychiatric illness: Robins and Guze's method revisited. In: The Validity of Psychiatric Diagnosis. Edited by LN Robins, JE Barrett. New York, Raven Press, 1989, pp. 9–18
12. Conners CK: Methodology of antidepressant drug trials for treating depression in adolescents. J Child Adol Psychopharm 2:11–22, 1992
13. Davidson J, Turnbull C, Strickland R, Belyea M: Comparative diagnostic criteria for melancholia and endogenous depression. Arch Gen Psychiatry 41:506–511, 1984
14. Downey G, Coyne JC: Children of depressed parents: An integrative review. Psychol Bull 108:50–76, 1990
15. Fendrich M, Warner V, Weissman MM: Family risk factors, parental depression, and psychopathology in offspring. Dev Psychol 26:40–50, 1990
16. Fine S, Forth A, Gilbert M, Haley G: Group therapy for adolescent depressive disorder: A comparison of social skills and therapeutic support. J Am Acad Child Adol Psychiatry 30:79–85, 1991
17. Frank E, Kupfer D, Perel JM, Comes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093–1099, 1990
18. Geller B, Cooper TB, McCombs HG, Graham DL, Wells JM: Double-blind placebo-controlled study of nortriptyline in depressed children using a ‘fixed plasma level’ design. Psychopharm Bull 25:101–108, 1989
19. Geller B, Graham DL, Marsteller FA, Bryant M: Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a ‘fixed plasma level’ design. Psychopharm Bull 26:85–90, 1990
20. Glassman AH, Perel JM, Shostak M, Kanton SJ, Fleiss JL: Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 34:197–204, 1977
21. Goldman-Rakic P, Brown RM: Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 4:339–349, 1982
22. Grove WM, Andreasen NC: Quantitative and qualitative distinctions between psychiatric disorders. In: The Validity of Psychiatric Diagnosis. Edited by LN Robins, JE Barrett. New York, Raven Press, 1989, pp 127–141
23. Hammen C, Burge D, Burney E, Adrian C: Longitudinal study of diagnoses in children of women with unipolar and bipolar affective disorder. Arch Gen Psychiatry 47:1112–1117, 1990
24. Harrington R, Fudge H, Rutter M, Pickles A, Hill J: Adult outcomes of child and adolescent depression. Arch Gen Psychiatry 47:465–473, 1990
25. Kashani JH, Shekim WO, Reid JC: Amitryptyline in children with major depressive disorder: A double-blind crossover pilot study. J Am Acad Child Adol Psychiatry 23:348–351, 1984
26. Kazdin AE: Childhood depression. J Child Psychol Psychiatry 31:121–160, 1990
27. Kendell RE: The classification of depressions: A review of contemporary confusion. Br J Psychiatry 129:15–28, 1976
28. Kendell RE: Clinical validity. In: The Validity of Psychiatric Diagnosis. Edited by LN Robins, JE Barrett. Raven Press, New York, 1989, pp 305–323
29. Kocsis JH, Hanin I, Bowden C, Brunswick D, Ramsey A, Butler T, Frazer; A: Imipramine and amitriptyline plasma concentrations and clinical response in major depression. Br J Psychiatry 148:52–57, 1986
30. Koplewicz H, Klass E, Klein R: Preliminary data of a study of the efficacy of desipramine in the treatment of adolescents with major depressive disorder. Presented at the 30th Annual Meeting of the NIMH New Clinical Drug Evaluation Unit, Key Biscayne, Florida, May, 1990
31. Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R: Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 41:229–237, 1984a
32. Kovacs M, Feinberg TL, Crouse-Novak M, Paulauskas SL, Pollock M, Finkelstein R: Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 41:643–649, 1984b
33. Kovacs M, Paulauskas SL: Developmental stage and the expression of depressive disorders in children: An empirical analysis. In: Childhood Depression: New Directions for Child Development, vol. 26, Edited by D Cicchetti, K Schneider-Rosen. Jossey-Bass, San Francisco, 1984, pp 59–79
34. Kraemer AD, Feiguine RJ: Clinical effects of amitriptyline in adolescent depression. A pilot study. J Am Acad Child Psychiatry 20:636–644, 1981
35. Kragh-Sorensen P, Hansen C, Gaastrup T, Hvidberg E: Self-inhibiting action of nortriptyline to antidepressant effects at high plasma levels: A randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. Psychopharmacologia 45:305–312, 1976
36. Lewinsohn PM, Clarke GN, Hops H, Andrews J: Cognitive-behavioral treatment for depressed adolescents. Behav Ther 21:385–401, 1990
37. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricano E, Markowitz JS, Klein DR: Phenelzine versus imipramine in atypical depression: A preliminary report. Arch Gen Psychiatry 41:669–677, 1984
38. Lucas HR, Lockert HJ, Grimm F: Amitriptyline in childhood depression. Dis Nerv Syst 26:105–110, 1965
39. Moreau D, Mufson L, Weissman MM, Klerman GL: Interpersonal psychotherapy for adolescent depression: Description of modification and preliminary application. J Am Acad Child Adol Psychiatry 30:642–651, 1991
40. Morris JB, Beck AT: The efficacy of antidepressant drugs. Arch Gen Psychiatry 30:667–674, 1974
41. Murrin LC, Gibbens DL, Ferrer JR: Ontogeny of dopamine, serotonin, and spirocecanone receptors in rat forebrain: An autoradiographic study. Dev Brain Res 23:91–109, 1985
42. Nordberg A: The aging of cholinergic synapses: Ontogenesis of cholinergic receptors. In: Dynamics of Cholinergic Function. Edited by I Hanin. New York, Plenum, pp. 165–175, 1986
43. Petti TA, Law W: Imipramine treatment of depressed children: A double-blind study. J Clin Psychopharm 2:107–110, 1982
44. Piacentini J, Jensen PS, Shaffer D, Richters J, Roper M, Bourdon K, Davies M, Chen J: Attenuation of child psychiatric diagnostic information: A detailed analysis. Proc Ann Meet Am Acad Child Adol Psychiatry, San Francisco, October 1991, p.78
45. Preskorn SH, Weller EB, Weller RA: Depression in children: Relationship between plasma imipramine levels and response. J Clin Psychiatry 43:450–453, 1982
46. Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Shea C, Tabrizi MD, Stiller B: Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: A preliminary report. J Am Acad Child Psychiatry 18:616–627, 1979
47. Puig-Antich J, Lukens E, Davies M, Goetz D, Brennan-Quattrock J, Todak G: Psychosocial functioning in prepubertal major depressive disorders. I. Interpersonal relationships during the depressive episode. Arch Gen Psychiatry 42:500–507, 1985a
48. Puig-Antich J, Lukens E, Davies M, Goetz D, Brennan-Quattrock J, Todak G: Psychosocial functioning in prepubertal major depressive disorders. II. Interpersonal relationships after sustained recovery from affective episode. Arch Gen Psychiatry 42:511–517, 1985b
49. Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Tabrizi MA, King J, Goetz R, Davies M, Stiller RL: Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 44:81–89, 1987
50. Quitkin FM, Rifkin A, Klein DF: Imipramine response in deluded depressive patients. Am J Psychiatry 135:806–811, 1978
51. Quitkin FM, Rabkin JG, Ross D, Stewart J: Identification of true drug response to antidepressants: Use of pattern analysis. Arch Gen Psychiatry 41:782–786, 1984
52. Raskin A: Age-sex differences in response to antidepressant drugs. J Nerv Ment Dis 159:120–130, 1975
53. Reimherr FW, Wood DR, Byerley B, Brainard J, Brosser BI: Characteristics of responders to fluoxetine. Psychopharm Bull 20:70–72, 1984
54. Rie HE: Depression in childhood: A survey of some pertinent contributions. J Am Acad Child Psychiatry 5:653–685, 1966
55. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 126:983–987, 1970
56. Robinson LA, Berman JS, Neimeyer RA: Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research. Psych Bull 108:30–49, 1990
57. Rochlin G: The loss complex: A contribution to the etiology of depression. J Am Psychoanal Assoc 7:299–316, 1959
58. Rutter M: Some focus and process considerations regarding effects of parental depression on children. Dev Psychol 26:6067, 1990
59. Ryan ND: Pharmacotherapy of adolescent major depression: beyond TCAs. Psychopharm Bull 26:75–79, 1990
60. Ryan ND, Meyer V, Dachille S, Mazzie D, Puig-Antich J: Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adol Psychiatry 27:371–376, 1988a
61. Ryan ND, Puig-Antich J, Rabinovich H, Fried J, Ambrosini P, Meyer V, Torres D, Dachille S, Mazzie D: MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. J Am Acad Child Adol Psychiatry 27:755–758, 1988b
62. Ryan ND, Perel J: A controlled study of amitriptyline versus placebo in adolescent MDD. Presented at the 36th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York City, New York, 1989
63. Ryan ND, Puig-Antich J, Cooper TB, Rabinovich H, Ambrosini P, Davies M, King J, Torres D, Fried J: Imipramine in adolescent major depression: Plasma level and clinical response. Acta Psychiatr Scand 73:275–288, 1986
64. Shapiro AK, Morris LA: The placebo effect in medical and psychological therapies. In: The Handbook of Psychotherapy and Behavior Change. Edited by SL Garfield, AE Bergin. New York, John Wiley and Sons, pp 369–410, 1978
65. Simpson GM, White KL, Boyd JL, Cooper TB, Halaris A, Wilson IC, Raman EJ, Ruther E: Relationship between plasma antidepressant level and clinical outcome for inpatients receiving imipramine. Am J Psychiatry 139:358–360, 1982
66. Spiker D, Cofsky J, Dealy RF, Griffin SJ, Hanin I, Neil JF, Perel J, Rossi AJ, Soloff PH: Pharmacologie treatment of delusional depression. Am J Psych 142:430–436, 1985
67. Strober M, Freeman R, Rigali J: The pharmacotherapy of depressive illness in adolescence. I. An open label trial of imipramine. Psychopharm Bull 26:80–84, 1990
68. Strober M, Lampert C, Schmidt S, Morrell W: The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a 24-month prospective, naturalistic follow-up of psychotic and non-psychotic subtypes. J Am Acad Child Adolesc Psychiatry, in press
69. Strober M: The pharmacotherapy of depressive illness in adolescence: III. Diagnostic and conceptual issues in studies of tricyclic antidepressants. J Child Adol Psychopharmacol 2(1):23–29, 1992
70. Weinberg WA, Rutman J, Sullivan K, Penick EC, Dietz SG: Depression in children referred to an educational diagnostic center. J Pediatr 80:1065–1072, 1973
71. Weissman MM, Gammon D, John K, Merikangas KR, Warner V, Prusoff BA, Sholomskas D: Children of depressed parents: Increased psychopathology and early onset of major depression. Arch Gen Psychiatry 44:847–853, 1987
72. Weissman MM, Warner V, Wickramaratne P, Prusoff BA: Early-onset major depression in parents and their children. J Affective Dis 15:268–277, 1988
73. Wilkes TCR, Rush JA: Adaptations of cognitive therapy for depressed adolescents. J Am Acad Child Adol Psychiatry 27:381–386, 1988
74. Yaylayan SA, Weller EB, Weller RA: Biology of depression in children and adolescents. J Child Adol Psychopharmacol 1:215–227, 1990